Abeona Therapeutics
(ABEO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,836 | -2,526 | -1,080 | -3,300 | -2,390 |
| Depreciation Amortization | 333 | 223 | 111 | 280 | 170 |
| Accounts receivable | -352 | -52 | -124 | -88 | N/A |
| Other Working Capital | 272 | 410 | 284 | -240 | -120 |
| Other Operating Activity | 352 | 52 | 124 | 108 | 350 |
| Operating Cash Flow | $-3,231 | $-1,893 | $-685 | $-3,240 | $-1,990 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,676 | -12,519 | -10,960 | N/A | N/A |
| PPE Investments | -68 | -63 | -38 | -5 | -3 |
| Net Acquisitions | N/A | N/A | N/A | -100 | -100 |
| Other Investing Activity | 0 | 0 | 0 | 5 | 3 |
| Investing Cash Flow | $-19,744 | $-12,582 | $-10,998 | $-100 | $-100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,622 | N/A | N/A | N/A | N/A |
| Debt Repayment | -26 | -26 | -20 | -97 | N/A |
| Common Stock Repurchased | -752 | -750 | -750 | N/A | N/A |
| Other Financing Activity | 17,428 | 15,381 | 15,003 | 2,827 | 2,630 |
| Financing Cash Flow | $29,272 | $14,605 | $14,233 | $2,730 | $2,630 |
| Beginning Cash Position | 869 | 869 | 869 | 1,480 | 1,480 |
| End Cash Position | 7,166 | 999 | 3,419 | 860 | 2,020 |
| Net Cash Flow | $6,297 | $130 | $2,550 | $-610 | $530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,231 | -1,893 | -685 | -3,240 | -1,990 |
| Capital Expenditure | -68 | -63 | -38 | -5 | N/A |
| Free Cash Flow | -3,299 | -1,956 | -723 | -3,245 | -1,990 |